Tilray Brands, Inc.

TLRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $226.0M $221.7M $228.3M $206.6M $415.9M $488.5M $189.7M $96.8M
Accounts Receivable $189.2M $121.5M $101.7M $86.2M $95.3M $87.3M $29.0M $36.2M
Inventory $301.2M $270.9M $252.1M $200.6M $245.5M $256.4M $93.6M $87.9M
Total Current Assets $792.1M $688.6M $677.7M $773.0M $803.5M $883.6M $347.0M $259.0M
Property, Plant & Equipment $680.2M $568.4M $558.2M $429.7M $587.5M $650.7M $199.6M $184.2M
Goodwill $752.4M $752.4M $2.01B $2.01B $2.64B $2.83B $166.9M $163.3M
Intangible Assets (Excl. Goodwill) $42.8M $21.4M $915.5M $973.8M $1.28B $1.61B $186.4M $228.8M
Total Assets $2.33B $2.07B $4.22B $4.31B $5.45B $6.03B $945.9M $896.3M
Liabilities
Accounts Payable $114.5M $235.3M $105.4M $70.8M $68.6M $57.7M $17.8M $39.1M
Total Current Liabilities $358.4M $280.3M $299.2M $433.0M $280.3M $401.2M $181.3M $92.4M
Long-Term Debt — — — — $117.9M $167.5M $94.0M —
Total Liabilities $733.1M $584.8M $778.5M $977.3M $1.01B $1.56B $572.1M $611.1M
Stockholders' Equity
Retained Earnings $-4.97B $-4.85B $-2.66B $-2.42B $-962.9M $-486.1M $-730.1M $-430.1M
Total Stockholders' Equity $1.61B $1.51B $3.44B $3.32B $4.40B $4.46B $373.9M $285.3M
← Newer Page 1 of 2 Older →